Dinaciclib
CDK1/2/5/9 Inhibitor
- CAS
- 779353-01-4
- Formula
- C21H28N6O2
- Mol. weight
- 396.49 g/mol
- Purity
- ≥99%
Added. View your enquiry →
Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.
Dinaciclib is a potent pan-CDK inhibitor with sub-nanomolar activity against CDK1, 2, 5, and 9. Unlike selective CDK4/6 inhibitors, it induces apoptosis rather than cytostasis by disrupting both cell cycle progression and transcriptional elongation (via CDK9/P-TEFb). Extensively studied in preclinical haematological and solid tumour models.
Target class: CDK inhibitors
Research areas: Breast Cancer, Leukemia, Lung Cancer
Related compounds
| SMILES | CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO |
|---|---|
| InChIKey | PIMQWRZWLQKKBJ-SFHVURJKSA-N |
